HealthEquity Inc (2HE.SG)
| Previous close | 72.50 |
| Open | 73.00 |
| Bid | 73.50 x 0 |
| Ask | 74.00 x 0 |
| Day's range | 73.00 - 73.00 |
| 52-week range | 48.80 - 78.50 |
| Volume | |
| Avg. volume | 2 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Team Member Feedback Earns HealthEquity Workplace Culture Recognition
For the fourth consecutive year, team members' feedback has propelled HealthEquity to be recognized for cultural excellenceDRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest Health Savings Account (HSA) custodian has received a Culture Excellence Award by Top Workplaces for the fourth consecutive year. "Our teammates deserve all the credit when it comes to this award,” said Cheryl King, executive vice president and chief human resource officer.
- GlobeNewswire
Benefits Leaders Believe in Power of AI, Considering Data Privacy and Accuracy
New study indicates that benefits professionals are in an ‘early adopter’ stage with AIDRAPER, Utah, April 04, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") released the findings of a new survey on Artificial Intelligence (AI) in benefits administration. The survey provides a benchmark on senior benefit leaders’ attitude toward AI-enabled benefits tools. A majority (73%) of the more than 800 respondents surveyed believe that AI will have a positive influence on benef
- GlobeNewswire
HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results
Highlights of the fiscal year include: Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23.Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million, compared to $114.5 million in FY23.Net income per diluted share of $0.64, compared to net loss per diluted share of $0.31 in FY23, with non-GAAP net income per diluted share of $2.25, compared to $1.36 in FY23.Adjusted EBITDA of $369.2 million, an increase of
